Testing Utility of Commercially Available Sleep Trackers for Physician-Patient Communication
1 other identifier
interventional
200
1 country
1
Brief Summary
Sleep related disorders are common in primary care practice. Sleep wear related data has not been utilized to improve sleep related communication between patients and providers. The study team is conducting a randomized study to improve physical-patient communication regarding sleep through a novel intervention based upon sleep wear and the Sleeplife® app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2018
CompletedStudy Start
First participant enrolled
June 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedFirst Posted
Study publicly available on registry
January 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2019
CompletedJanuary 7, 2019
January 1, 2019
7 months
May 3, 2018
January 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of physicians using a commercially available sleep tracker assessed by the "Physician Satisfaction/Communication" questionnaire who saw an improvement in physician-patient dialogue regarding sleep and related behaviors and habits
For patient-physician communications from the physicians' end, the team will collect all scores, ranging from 1 to 5, for all the "Communication" questions in the "Physician Satisfaction/Communication" questionnaire. The scores will be summed up as the total communication score from physician, and the total score will be treated as continuous response variable. Then a binary variable indicating whether the physician is in the intervention (=1) or control (=0) arm will be treated as the main explanatory variable, a continuous variable regarding the time where the measurements are recorded, and the set of general demographic variables (age, race, gender, etc) will be used as covariates. We will use linear regression model, and select relevant variables using Bayesian information criterion (BIC) in a step-wise manner. The SleepLife app will be pulling time-to-sleep (TST), amount of time in minutes to sleep, number of awakenings greater than 5 minutes, and sleep efficiency.
Six Months
Number of patient-physician communicationdialog assessed by using a commercially available sleep tracker assessed by the "Patient Satisfaction" questionnaire.
For patient-physician communications from the patients' end, the team will collect all the scores, ranging from 1 to 5, for all the "Communication" questions in the "Patient Satisfaction" questionnaire. The scores will be summed up as the total communication score from the patients' end, and the total score will be treated as continuous response variable. Then a binary variable indicating whether the patient is in the intervention (=1) or control (=0) arm will be treated as the main explanatory variable, a continuous variable regarding the time where the measurements are recorded, and the set of general demographic variables (age, race, gender, etc) will be used as covariates. Considering the linear responses and the cluster design, the team will use generalized estimating equation (GEE) model with an identity link function, and the team will select relevant variables using QIC in a step-wise manner.
Six Months
Secondary Outcomes (2)
Number of physician subjects with satisfaction with sleep counseling that improves when presented with objective patient sleep data.
Six Months
Number of patients who feel that their communication with their physician has improved as a result of the program as measured by the "Patient Satisfaction" survey.
Six Months
Other Outcomes (1)
To determine if data improves over time for measures related to total sleep time (TST) and satisfaction with sleep.
Six Months
Study Arms (2)
SleepLife Application w/FitBit
EXPERIMENTALSubject receives a FitBit. Subjects receive access to the SleepLife Application. Subjects receive training and assistance setting up use and access to the SleepLife Application. Subject physicians will receive subject sleep data. Subject and physicians have the option of messaging each other through the SleepLife application.
FitBit w/Minimal to No SleepLife App.
ACTIVE COMPARATORSubjects will receive a FitBit Subjects will be told about the SleepLife Application (but not be shown how to access it). Subjects will receive no training with regard to how to access SleepLife Application. Subjects' physicians will receive no subject sleep data.
Interventions
Subjects receive a FitBit. Subjects receive access to the SleepLife Application. Subjects receive training and assistance setting up use and access to the SleepLife Application. Subjects' physicians will receive subject sleep data. Subjects and physicians have the option of messaging each other through the SleepLife application.
Subjects will receive a FitBit. Subjects will be told about the SleepLife Application (but not be shown how to access it). Subjects will receive no training with regard to how to access SleepLife Application. Subjects' physicians will receive no subject sleep data.
Eligibility Criteria
You may qualify if:
- and older
- Have insomnia as identified by electronic record and/or a validated questionnaire
- Prescription medication for insomnia with International Classification of Disease (ICD) codes: 327.\*, 780.5\*, 347.\*; icd-10's G47\* and medications: Ambien (zolpidem), Belsomra (suvorexant), Butisol (butabarbital), Doral (quazepam), Edluar (zolpidem), Estazolam, Flurazepam, Halcion (triazolam), Hetlioz (tasimelteon), Intermezzo (zolpidem), Lunesta (eszopiclone), Restoril (temazepam), Rozerem (ramelteon), Seconal (secobarbital), Silenor (doxepin), Sonata (zaleplon), and Zolpimist (zolpidem)
- \. English speaking 4. Consentable in-person 5. Have access to a telephone with smart phone capabilities. (iOS/Android)
You may not qualify if:
- Not English speaking
- Have ischemic or hemorrhagic cerebrovascular disease affecting collection of study outcomes (via ICD codes I6\*, 43\*)
- History of dementia (via ICD codes F0\*, 290\*)
- History of Bipolar/Schizophrenia/Depression (via ICD codes F2\*, F31\*, 296\*, 295\*)
- History of alcohol or substance abuse (via ICD codes F1\*, 304\*, 303\*)
- Incarcerated/Long Term Care (LTC)
- Unable to complete study questionnaires due to hearing loss or blindness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Regenstrief Institute, Inc.lead
- Merck Sharp & Dohme LLCcollaborator
- National Sleep Foundationcollaborator
Study Sites (1)
Regenstrief Institute
Indianapolis, Indiana, 46202, United States
Related Publications (12)
Fox S, & Duggan M. Tracking for health. Pew Research Center, Pew Internet and American Life Project. 2013.
RESULTEvenson KR, Goto MM, Furberg RD. Systematic review of the validity and reliability of consumer-wearable activity trackers. Int J Behav Nutr Phys Act. 2015 Dec 18;12:159. doi: 10.1186/s12966-015-0314-1.
PMID: 26684758RESULTde Zambotti M, Baker FC, Willoughby AR, Godino JG, Wing D, Patrick K, Colrain IM. Measures of sleep and cardiac functioning during sleep using a multi-sensory commercially-available wristband in adolescents. Physiol Behav. 2016 May 1;158:143-9. doi: 10.1016/j.physbeh.2016.03.006. Epub 2016 Mar 9.
PMID: 26969518RESULTde Zambotti M, Claudatos S, Inkelis S, Colrain IM, Baker FC. Evaluation of a consumer fitness-tracking device to assess sleep in adults. Chronobiol Int. 2015;32(7):1024-8. doi: 10.3109/07420528.2015.1054395.
PMID: 26158542RESULTKnutson KL, Phelan J, Paskow MJ, Roach A, Whiton K, Langer G, Hillygus DS, Mokrzycki M, Broughton WA, Chokroverty S, Lichstein KL, Weaver TE, Hirshkowitz M. The National Sleep Foundation's Sleep Health Index. Sleep Health. 2017 Aug;3(4):234-240. doi: 10.1016/j.sleh.2017.05.011. Epub 2017 Jun 20.
PMID: 28709508RESULTHays, R.D., Davies, A.R., & Ware, J.E. (1987). Scoring the medical outcomes study patient satisfaction questionnaire: PSQ-III. MOS Memorandum.
RESULTCampbell C, Lockyer J, Laidlaw T, Macleod H. Assessment of a matched-pair instrument to examine doctor-patient communication skills in practising doctors. Med Educ. 2007 Feb;41(2):123-9. doi: 10.1111/j.1365-2929.2006.02657.x.
PMID: 17269944RESULTCharlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr. Resuscitation: how do we decide? A prospective study of physicians' preferences and the clinical course of hospitalized patients. JAMA. 1986 Mar 14;255(10):1316-22. doi: 10.1001/jama.255.10.1316.
PMID: 3944949RESULTKATZ S, FORD AB, MOSKOWITZ RW, JACKSON BA, JAFFE MW. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963 Sep 21;185:914-9. doi: 10.1001/jama.1963.03060120024016. No abstract available.
PMID: 14044222RESULTLawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969 Autumn;9(3):179-86. No abstract available.
PMID: 5349366RESULTD'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993 Nov;32(5):382-7.
PMID: 8295545RESULTHerr KA, Garand L. Assessment and measurement of pain in older adults. Clin Geriatr Med. 2001 Aug;17(3):457-78, vi. doi: 10.1016/s0749-0690(05)70080-x.
PMID: 11459715RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Babar Khan, MD
Regenstrief Institute, Inc.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Masking will not occur.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2018
First Posted
January 7, 2019
Study Start
June 10, 2018
Primary Completion
December 31, 2018
Study Completion
February 28, 2019
Last Updated
January 7, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share
The Regenstrief research team will use Protected Health Information (PHI) to conduct this study. Data that does not identify the subject will be shared with Merck Sharp \& Dohme Corp. and the National Sleep Foundation. At this time, that is only the study visit day.